Lab21

Lab21

Rapidly growing healthcare diagnostics business the company’s vision is of providing personalised diagnostic testing for.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round

€40.0m

Valuation: €40.0m

Acquisition
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
GBP2012201320142015201620172018
Revenues0000000000000000000000000000
% growth1 %(39 %)(90 %)(6 %)(3 %)13 %(6 %)
EBITDA0000000000000000000000000000
% EBITDA margin(44 %)(19 %)(504 %)(52 %)(130 %)(92 %)(739 %)
Profit0000000000000000000000000000
% profit margin(66 %)(69 %)(603 %)(106 %)(162 %)(107 %)(853 %)
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000

Source: Company filings or news article

More about Lab21
Made with AI
Edit

Cambridge Clinical Laboratories (CCL), based in Cambridge, UK, specializes in providing advanced testing services to healthcare professionals globally. Operating from UKAS accredited facilities, CCL offers a wide range of molecular and viral diagnostics, next-generation sequencing, pharmacogenetic, and patient profiling tests. The company serves both NHS and private customers, ensuring fast and accurate diagnostics to improve treatment outcomes. CCL's business model revolves around offering high-quality, personalized healthcare testing options with a commitment to quick turnaround times, secure sample collection, and clear results. Revenue is generated through the provision of these specialized diagnostic services to healthcare providers and institutions.

Keywords: molecular diagnostics, viral diagnostics, next-generation sequencing, pharmacogenetics, patient profiling, UKAS accredited, personalized healthcare, rapid turnaround, secure sample collection, Cambridge UK.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Lab21

Edit
Delphic Diagnostics
ACQUISITION by Lab21 Sep 2009
Myconostica
ACQUISITION by Lab21 May 2011